NEW YORK ( TheStreet) -- CHANGE IN RATINGS
Amerigroup (AGP) rated new Buy at Jefferies. $100 price target. Company is leveraged to a robust Medicaid RFP pipeline.
Accretive Health (AH) downgraded from Outperform to Neutral at at Baird. $21 price target. Company just lost a major contract.
BJ's Restaurants (BJRI) rated new Overweight at Morgan Stanley. $59 price target. Company can deliver above-average growth over the next several quarters.Gap (GPS - Get Report) upgraded at Janney from Neutral to Buy. $33 price target. Better merchandising can drive inventory improvement. Hecla Mining (HL) rated new Hold at Deutsche Bank. $5.50 price target. Lucky Mine remains closed. Invensense (INVN) downgraded to Perform at Oppenheimer. Valuation call, based on a $15 price target. Lufkin (LUFK) rated new Buy at Dahlman Rose. $96 price target. Company has solid pricing power, which could drive higher margins. Lululemon Athletica (LULU) rated new Buy at UBS. $91 price target. Early innings of sales growth across channels and geographies. Molina Healthcare (MOH) rated new Hold at Jefferies. Valuation call, as the stock is up 51% year-to-date. $37 price target. Research in Motion (RIMM) downgraded at FBR Capital Markets from Market Perform to Underperform. $11 price target. Potential turnaround will likely take longer to develop. United Natural (UNFI) rated new Sell at Cantor Fitzgerald. $33 price target. Earnings growth could lag sales. US Bancorp (USB) downgraded at BMO Capital from Outperform to Market Perform. Valuation call, based on a $34 price target. Vivus (VVUS) upgraded at Brean Murray to Buy, Brean. $30 price target. FDA appears to see more favorable results to weight loss. Westport (WPRT) rated new Buy at Capstone. $49 price target. Demand should continue to grow for natural gas engines.
STOCK COMMENTS / EPS CHANGESApple (AAPL) estimates were raised by BMO Capital through 2013. iPad should continue to drive near-term growth, BMO said. Outperform rating and new $675 price target. Best Buy (BBY) target lowered at UBS to $26. Stores lack a near term catalyst, UBS said. Neutral rating. DirecTV (DTV) numbers raised at UBS. Shares of DTV are now seen reaching $50. Estimates also increased on bullish outlook for Latin America. Neutral rating. DirecTV (DTV) estimates increased through 2014 at at Credit Suisse. Latin America is driving growth, Credit Suisse said. Neutral rating and $53 price target. Education Management (EDMC) estimates were cut through 2014, Morgan Stanley said. New term loan will cut into earnings. Equal-weight rating and new $14 price target. Intel (INTC) target boosted at ThinkEquity. Shares of INTC now seen reaching $35, according to ThinkEquity. Survey points to increased IT spending. Buy rating. Mosaic (MOS) estimates lowered at UBS through 2013, UBS said. 3Q disappoints, but intrinsic value intact, UBS said. Buy rating. Mosaic MOS estimates, target cut at Morgan Stanley. Shares of MOS now seen reaching $70, according to Morgan Stanley. Estimates also reduced, given an expected delay in dealer restocking. Overweight rating. Research in Motion (RIMM) estimates slashed at UBS RIMM estimates slashed through 2014, UBS said. Tough quarter with no guidance provided. Neutral rating and $15 price target. Research in Motion (RIMM) numberes lowered at Citigroup. Shares of RIMM now seen reaching $11.75, Citigroup said. Estimates also lowered on the unit growth deceleration, inventory build, and lack of outlook. Sell rating. Research in Motion (RIMM) estimates lowered at Credit Suisse through 2014. Company continues to have poor visibility, Credit Suisse said. Neutral rating and new $14.50 price target. Shaw (SHAW) estimates, target raised at Credit Suisse. Shares of SHAW now seen reaching $36, according to Credit Suisse. Estimates also increased, as the company continues to execute well. Neutral rating. Tibco (TIBX) estimates, target boosted at BMO Capital. Shares of TIBX now seen reaching $30, according to BMO Capital. Estimates also upped, to match the company's new guidance. Market Perform rating. United Continental (UAL) estimates lowered at UBS through 2013. March top line shows little improvement, UBS said. Buy rating and $33 price target. Worthington (WOR) estimates, target boosted at Jefferies through 2013. Company is seeing solid growth, despite weaker industry trends, Jefferies said. Buy rating and new $24 price target. >To submit a news tip, email: firstname.lastname@example.org.
Follow TheStreet on Twitter and become a fan on Facebook.